JEWISH GENERAL HOSPITAL
Vitamin Therapy in JGH Patients
- Conditions
- Interventions
- First Posted Date
- 2012-06-28
- Last Posted Date
- 2018-03-02
- Lead Sponsor
- Jewish General Hospital
- Target Recruit Count
- 88
- Registration Number
- NCT01630720
- Locations
- 🇨🇦
Jewish General Hospital, Montreal, Quebec, Canada
Hypotonic Treprostinil Subcutaneous Infusion for Control of Treprostinil Related Site Pain
- Conditions
- Interventions
- First Posted Date
- 2012-06-08
- Last Posted Date
- 2020-03-03
- Lead Sponsor
- Jewish General Hospital
- Registration Number
- NCT01615627
- Locations
- 🇨🇦
Jewish General Hospital, Montreal, Quebec, Canada
Lidocaine Subcutaneous Infusion for Control of Treprostinil Related Site Pain
- First Posted Date
- 2011-09-13
- Last Posted Date
- 2023-02-01
- Lead Sponsor
- Jewish General Hospital
- Target Recruit Count
- 4
- Registration Number
- NCT01433328
- Locations
- 🇨🇦
Jewish General Hospital, Montreal, Quebec, Canada
Meaning-based Group Counselling for Bereavement
- Conditions
- Interventions
- First Posted Date
- 2011-06-29
- Last Posted Date
- 2013-11-08
- Lead Sponsor
- Jewish General Hospital
- Target Recruit Count
- 26
- Registration Number
- NCT01384942
- Locations
- 🇨🇦
S.M.B.D. Jewish General Hospital / Hope and Cope Program, Montreal, Quebec, Canada
Phase I/II Study of Ribavirin Given as Monotherapy in Solid Tumour Cancer Patients
- First Posted Date
- 2011-03-07
- Last Posted Date
- 2011-03-07
- Lead Sponsor
- Jewish General Hospital
- Target Recruit Count
- 37
- Registration Number
- NCT01309490
- Locations
- 🇨🇦
Jewish General Hospital, Montreal, Quebec, Canada
Study to Identify Molecular Mechanisms of Clinical Resistance to Chemotherapy in Triple Negative Breast Cancer Patients
- Conditions
- Interventions
- First Posted Date
- 2011-01-13
- Last Posted Date
- 2022-06-02
- Lead Sponsor
- Jewish General Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT01276899
- Locations
- 🇺🇸
John H. Stroger, Jr. Hospital of Cook County, Chicago, Illinois, United States
🇨🇦Centre Hospitalier de l'Université de Montréal -- Hotel-Dieu, Montreal, Quebec, Canada
🇨🇦Centre Hospitalier de l'Université de Montréal- Notre-Dame, Montreal, Quebec, Canada
Use of Ribavirin and Low Dose Ara-C to Treat Acute Myeloid Leukemia
- Conditions
- Interventions
- First Posted Date
- 2010-01-26
- Last Posted Date
- 2023-10-02
- Lead Sponsor
- Jewish General Hospital
- Target Recruit Count
- 29
- Registration Number
- NCT01056523
- Locations
- 🇨🇦
Jewish General Hospital, Montreal, Quebec, Canada
Treatment With Ribavirin for Patients With Metastatic Breast Cancer
- First Posted Date
- 2010-01-26
- Last Posted Date
- 2015-11-04
- Lead Sponsor
- Jewish General Hospital
- Target Recruit Count
- 4
- Registration Number
- NCT01056757
- Locations
- 🇨🇦
Jewish General Hospital, Montreal, Quebec, Canada
Trial of Chemotherapy Plus Intravenous Vitamin C in Patients With Advanced Cancer for Whom Chemotherapy Alone is Only Marginally Effective
- Conditions
- First Posted Date
- 2010-01-15
- Last Posted Date
- 2013-06-21
- Lead Sponsor
- Jewish General Hospital
- Target Recruit Count
- 14
- Registration Number
- NCT01050621
- Locations
- 🇨🇦
Clinical Research Unit, Jewish General Hospital, Montreal, Quebec, Canada
Study to Identify Mechanisms of Resistance to Standard Therapy in Patients With Metastatic Colorectal Cancer
- First Posted Date
- 2009-09-24
- Last Posted Date
- 2021-06-15
- Lead Sponsor
- Jewish General Hospital
- Target Recruit Count
- 160
- Registration Number
- NCT00984048
- Locations
- 🇨🇦
Hôpital Notre-Dame, Montreal, Quebec, Canada
🇨🇦Jewish General Hospital, Montreal, Quebec, Canada
🇨🇦McGill University Health Centre, Montreal, Quebec, Canada